reports
LifeWallet Announces a Comprehensive Settlement with 10 Affiliated Pro...
LifeWallet Announces a Comprehensive Settlement with 10 Affiliated Property & Casualty Insurers, Doing Business in 15 States CORAL GABLES, Fla., April 18, 2024 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) (“LifeWallet” or “the Company”) announces another comprehensive settlement with 10 affiliated property and casualty insurers (“P&C Insurers”) that write personal lines of P&C insurance in 15 states. In addition to settling existing claims, the settlement establishes a going-forward process to collaboratively and timely resolve future claims, as well as share imp...
Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-...
Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Histogen Inc. (HSTO, the “Company” or “Histogen”), a drug development company for treatment of bacterial skin infections, today announced that it has filed voluntary petitions for relief under subchapter V of Chapter 11 of the U.S. Bankruptcy Code (“Chapter 11”) in the United States Bankruptcy Court for the Southern District of California to confirm a plan of liquidation that will distribute all value to stakeholders, including shareholders. ...
First Western Reports First Quarter 2024 Financial Results
First Western Reports First Quarter 2024 Financial Results First Quarter 2024 Summary Net income available to common shareholders of $2.5 million in Q1 2024, compared to a Net loss of $3.2 million in Q4 2023.Diluted earnings/(loss) per share of $0.26 in Q1 2024, compared to $(0.34) in Q4 2023 Non-interest income increased 19.7% to $7.3 million compared to $6.1 million in Q4 2023 and 25.3% compared to $5.8 million in Q1 2023Loan to deposit ratio decreased to 98.4% in Q1 2024, compared to 100.6% in Q4 2023Book value per common share increased 0.8% from $25.33 in Q4 2023 to $25.52 in Q1 2024....
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Re...
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024 PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the release of the Company’s first quarter 2024 financial results to Monday, May 6, 2024. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. EDT. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the ...
NOVAGOLD Releases 2023 Sustainability Report
NOVAGOLD Releases 2023 Sustainability Report Providing a comprehensive overview of NOVAGOLD's Environmental, Social and Governance (ESG) performance, emphasizing remarkable health and safety records, steadfast dedication to environmental protection, continuous community investment, extensive stakeholder engagement, and robust corporate governance.Highlighting NOVAGOLD’s investment in our partnerships with Donlin Gold LLC, Calista Corporation (“Calista”), and The Kuskokwim Corporation (TKC) to reinforce Donlin Gold’s social license, while emphasizing ongoing community engagement and addressi...
Feutune Light Acquisition Corporation Announces Extension of the Deadl...
Feutune Light Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination Metuchen, NJ, April 18, 2024 (GLOBE NEWSWIRE) -- Feutune Light Acquisition Corporation (NASDAQ: FLFV) (the “Company”), a blank check company incorporated as a Delaware corporation, today announced that, in order to extend the date by which the Company must complete its initial business combination from April 21, 2024 to May 21, 2024, an aggregate of $60,000 has been deposited into Company’s trust account (the “Trust Account”). Pursuant to the Company’s Amended and Restated Certi...
Ascent Solar Technologies, Inc. Announces Second and Third Closings of...
Ascent Solar Technologies, Inc. Announces Second and Third Closings of Public Offering of Common Stock and Pre-Funded Warrants at $0.14 Per Share THORNTON, Colo., April 18, 2024 (GLOBE NEWSWIRE) -- Ascent Solar Technologies, Inc. (“Ascent Solar” or the “Company”) (NASDAQ: ASTI), a U.S. innovator in the design and manufacturing of featherweight, flexible thin-film photovoltaic (PV) solutions, today announced the second and third closings under its previously announced “best efforts” public offering, at a per share offering price of $0.14. 2,550,000 shares of common stock and 11,735,714 Pre...
Peloton Interactive, Inc. Announces Third Quarter Fiscal 2024 Earnings...
Peloton Interactive, Inc. Announces Third Quarter Fiscal 2024 Earnings Release Date, Conference Call, and Webcast NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (NASDAQ: PTON) will release its third quarter fiscal 2024 results before the U.S. stock market opens on Thursday, May 2, 2024. The company will host a conference call and live audio webcast to discuss the results at 8:30 a.m. (Eastern Time) that day. To access the call by phone, please visit this link for registration () to be provided with dial in details. To avoid delays, we encourage participants to...
Avicanna Announces Closing of Non-brokered Private Placement
Avicanna Announces Closing of Non-brokered Private Placement TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that it has closed a non-brokered private placement offering of 5,313,959 units of the Company (the “Units”) at a price of $0.40 per Unit for aggregate gross proceeds of approximately of $2,125,000. “We are very grateful to have the cont...
Provident Financial Services, Inc. Announces First Quarter Earnings an...
Provident Financial Services, Inc. Announces First Quarter Earnings and Declares Quarterly Cash Dividend ISELIN, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) (the “Company”) reported net income of $32.1 million, or $0.43 per basic and diluted share for the three months ended March 31, 2024, compared to $27.3 million, or $0.36 per basic and diluted share, for the three months ended December 31, 2023 and $40.5 million, or $0.54 per basic and diluted share, for the three months ended March 31, 2023. Net income for the trailing quarter ended December ...
California Water Service Group Moving Forward to Install PFAS Treatmen...
California Water Service Group Moving Forward to Install PFAS Treatment Despite CPUC Dismissal of Request to Track Capital Costs in Pre-Approved Memorandum Account SAN JOSE, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- California Water Service Group (Group) (NYSE: CWT) reaffirmed its commitment to investing an estimated $215 million in PFAS treatment and to working as quickly as possible to complete planned projects, despite a decision today by the California Public Utilities Commission to dismiss California Water Service’s (Cal Water’s) application requesting authorization to modify a prev...
Canadian General Investments: Report of Voting Results
Canadian General Investments: Report of Voting Results TORONTO, Canada, April 18, 2024 (GLOBE NEWSWIRE) -- This report is filed under section 16.3 of National Instrument 81-106 Investment Fund Continuous Disclosure in respect of the annual general meeting of shareholders of Canadian General Investments, Limited (the “Corporation”) held on April 18, 2024 (the “Meeting”). There were 14,432,001 common shares represented in person or by proxy at the Meeting (equal to 69.18% of the issued and outstanding common shares). Each of the seven nominees proposed by management for election as a dire...
Glacier Bancorp, Inc. Announces Results For The Quarter And Period End...
Glacier Bancorp, Inc. Announces Results For The Quarter And Period Ended March 31, 2024 1st Quarter 2024 Highlights: Net income was $32.6 million for the current quarter, a decrease of $21.7 million, or 40 percent, from the prior quarter net income of $54.3 million and a decrease of $28.6 million, or 47 percent, from the prior year first quarter net income of $61.2 million. The current quarter included a total of $13.3 million related to credit loss expense from the acquisition of Wheatland Bank, acquisition-related expense and increased expense from the Federal Deposit Insurance Corporati...
Glacier Bancorp, Inc. Receives Regulatory Approval for Acquisition of ...
Glacier Bancorp, Inc. Receives Regulatory Approval for Acquisition of Six Montana Branches From HTLF Bank KALISPELL, Mont., April 18, 2024 (GLOBE NEWSWIRE) -- Glacier Bancorp, Inc. (NYSE: GBCI) today announced that its banking subsidiary, Glacier Bank, has received all regulatory approvals required to complete its previously announced acquisition of six Montana branch locations of HTLF Bank (the “Branches”), the bank subsidiary of Heartland Financial USA, Inc. (NASDAQ: HTLF). The transaction is expected to be completed in July 2024, subject to customary closing conditions. The six branch...
Constellation Brands Announces Conversion of Common Shares and Exchang...
Constellation Brands Announces Conversion of Common Shares and Exchange of Promissory Note Into Exchangeable Shares of Canopy Growth Corporation VICTOR, N.Y., April 18, 2024 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today that its indirect, wholly-owned subsidiaries, Greenstar Canada Investment Limited Partnership (“Greenstar”) and CBG Holdings LLC (“CBG”), have converted (the "Conversion”) their common shares (“Common Shares”) of Canopy Growth Corporation (“Canopy”) into non-voting and non-participating exchangeable shares o...
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Result...
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024 LOWELL, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2024 financial results prior to the market open on Friday, May 3, 2024. In conjunction with the release, the Company’s management team will host a webcast conference call at 8:30 a.m....
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Upd...
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs BOSTON and ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases, today issued a Letter to Shareholders. Dear Fellow Shareholders of Inhibikase Therapeutics: 2024 has been off to a productive start for Inhibikase. ...
CN Announces Remi G. Lalonde as Chief Commercial Officer
CN Announces Remi G. Lalonde as Chief Commercial Officer MONTREAL, April 18, 2024 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) today announced the appointment of Remi G. Lalonde as Executive Vice-President and Chief Commercial Officer of CN effective April 24th, 2024. Remi is succeeding Doug MacDonald who will retire from CN following an impressive career of nearly 35 years. Since his arrival at CN in January, Remi has been embedded within CN’s operations, gaining first-hand experience with scheduled railroading and executing CN’s ‘Make the Plan, Run the Plan, Sell the Plan’ model. F...
Celularity Abstract “Emerging Technologies for the Management and Prot...
Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024 FLORHAM PARK, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, today announced that its abstract entitled “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” was accepted by the Orthopedic Resear...
Le CN annonce la nomination de Rémi G. Lalonde au poste de chef des ac...
Le CN annonce la nomination de Rémi G. Lalonde au poste de chef des activités commerciales MONTRÉAL, 18 avr. 2024 (GLOBE NEWSWIRE) -- Le CN (TSX : CNR) (NYSE : CNI) a annoncé aujourd’hui la nomination de Rémi G. Lalonde au poste de vice-président exécutif et chef des activités commerciales du CN, qui entre en fonction le 24 avril 2024. Rémi succède à Doug MacDonald qui prendra sa retraite du CN après une impressionnante carrière de près de 35 ans. Depuis son arrivée au CN en janvier, Rémi s’est imprégné des activités du CN pour acquérir une expérience pratique de l’exploitation ferro...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.